A Yersinia Effector with Enhanced Inhibitory Activity on the NF-κB Pathway Activates the NLRP3/ASC/Caspase-1 Inflammasome in Macrophages
2011

Yersinia Effector YopJ Activates Inflammasome in Macrophages

publication 10 minutes Evidence: high

Author Information

Author(s): Zheng Ying, Lilo Sarit, Brodsky Igor E., Zhang Yue, Medzhitov Ruslan, Marcu Kenneth B., Bliska James B.

Primary Institution: Stony Brook University

Hypothesis

The study investigates how the Yersinia effector YopJKIM enhances apoptosis and activates the caspase-1 inflammasome in macrophages.

Conclusion

YopJKIM has unique amino acid substitutions that enhance its ability to inhibit host signaling pathways, leading to increased apoptosis and caspase-1 activation in macrophages.

Supporting Evidence

  • YopJKIM causes increased apoptosis and caspase-1 activation compared to other YopJ isoforms.
  • Mutations in YopJKIM were shown to enhance its ability to inhibit host signaling pathways.
  • Activation of caspase-1 was confirmed in macrophages infected with Y. pestis expressing YopJKIM.

Takeaway

The Yersinia bacteria have a special protein that makes immune cells die in a way that can still cause inflammation, which is surprising because dying cells usually don't cause inflammation.

Methodology

The study used site-directed mutagenesis to analyze the effects of specific amino acid substitutions in YopJ on apoptosis and caspase-1 activation in macrophages.

Limitations

The study does not explore the long-term effects of YopJKIM on macrophage function or the immune response in vivo.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.1002026

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication